Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-25

Clinical Trial Update: Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Neoviderm Skin Emulsion to prevent radiation dermatitis has been terminated. The study involved head and neck cancer and breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neoviderm Skin Emulsion

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Head and Neck Cancer, Breast Cancer | Phase 2 | Status: TERMINATED